Abstract
Aldehyde dehydrogenase (ALDH) 1 is expressed in various stem/progenitor cells, including cancer-initiating cells (CICs). In the present study, ALDH1 expression was immuno-histochemically examined in diffuse large B-cell lymphoma (DLBCL). Unexpectedly, ALDH1 expression was occasionally detected in stromal cells, but not in lymphoma cells. Positively stained cells were CD68+ cells with voluminous cytoplasm and fascin+ cells with reticular morphology, designated as macrophages and dendritic cells (DCs), respectively. The presence of ALDH1+ macrophages was not correlated with stage, response to therapies and prognosis. However, cases with ALDH1+ DCs were mostly nodal, which showed a poorer response to therapies and a worse overall survival rate than cases without ALDH1+ DCs. The presence of ALDH1+ DCs appears to be involved in the malignant potential of DLBCL in lymph node.
Author supplied keywords
Cite
CITATION STYLE
Fujita, S., Morii, E., Rahadiani, N., Wada, N., Hori, Y., Ikeda, J. I., & Aozasa, K. (2011). Significance of aldehyde dehydrogenase 1 expression in stromal cells of diffuse large B-cell lymphoma. Experimental and Therapeutic Medicine, 2(4), 591–594. https://doi.org/10.3892/etm.2011.269
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.